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Abstract
Background: Children with haemophilia have lower levels of fitness and strength than their
healthy peers. We present the protocol of a study designed to determine whether an exercise
intervention improves quality of life, aerobic fitness and strength in children with haemophilia.
Methods/Design: The study will be a randomised, assessor-blinded, controlled trial of exercise
treatment. Seventy children aged between 6 and 18 years with haemophilia or von Willebrand
disease will be recruited from two paediatric haemophilia clinics in NSW. Each participant will be
allocated to an exercise group or a control group using a concealed allocation procedure. The
control group will receive usual medical care while the intervention group will receive usual medical
care plus an exercise program for 12 weeks. Outcomes (VO2peak, knee extensor strength and
quality of life) will be measured at baseline and on completion of the exercise program by a blinded
assessor. The primary analysis will be conducted on an intention to treat basis. The effects of the
exercise intervention on each of the three primary outcomes will be estimated from between-
group differences in the mean outcome adjusted for baseline scores.
Discussion: This study will be the first randomised controlled trial to examine the effects of a
structured exercise program on fitness and quality of life in children with haemophilia.
Background
Haemophilia A and B are X-linked recessive conditions
which affect 1 in 7,000 males in Australia [1]. They are
characterised by deficiency of Factor VIII or Factor IX (in
the mild and moderate forms) and absence of Factor VIII
or IX (in the severe form). Haemophilia is characterised
by an increased bleeding tendency, the severity of which
is dependent on the absolute levels of Factor VIII or IX.
Mild haemophilia (when the factor level is 5–40%) is
rarely associated with spontaneous bleeds. Moderate hae-
mophilia means that the factor level is <5% of normal and
severe haemophilia occurs when the factor level is <1%.
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The hallmarks of haemophilia are intramuscular and
intra-articular bleeds. Some children develop "target
joints" characterised by multiple bleeds into the same
joint which can lead to destruction of the joint surfaces
(haemophilic arthropathy).
In the past, children with haemophilia were often discour-
aged from physical activity due to a concern that this
would increase the risk of haemarthroses. The availability
of recombinant factor XIII has meant that children with
severe haemophilia can now have prophylactic therapy to
prevent spontaneous bleeds. A multi-centre study com-
paring prophylactic therapy with on-demand treatment in
young adults with severe haemophilia demonstrated
fewer joint bleeds and lower levels of arthropathy in the
prophylaxis group [2].
Even though children with haemophilia are now advised
to participate in physical activity, a number of studies,
including recent studies, have suggested that these chil-
dren have lower levels of fitness and strength when com-
pared with their healthy peers [3,4]. Unfortunately, these
studies have used samples that are not representative
(they sample small numbers of volunteers from haemo-
philia clinics) and it therefore remains unclear whether
children with haemophilia do in fact have lower levels of
fitness.
The therapeutic role of exercise in children with haemo-
philia has not been well documented but there is some
evidence that exercise can improve coagulation parame-
ters. Factor VIII levels have been shown to increase after a
single strenuous bout of exercise in non-haemophiliacs
[5,6]. A modest improvement in coagulation parameters
after an acute bout of exercise has also been shown in chil-
dren with mild and moderate haemophilia [7]. Whether
this improvement in coagulation parameters correlates
with frequency and severity of bleeding episodes remains
unclear. One pilot study which examined the effect of
resistance training on 5 adults with haemophilia reported
this type of training improved strength and reduced the
frequency and severity of bleeding episodes [8]. However,
the findings of this small and uncontrolled study cannot
be considered reliable. The effects of resistance training on
frequency and severity of bleeds needs to be tested in a
larger randomised controlled trial.
Studies which report positive effects from an exercise
intervention in adults with haemophilia have had very
small subject numbers and lacked experimental controls
[8]. Hilberg et al. [9] documented improvements in iso-
metric leg strength and proprioception in adults  with
severe haemophilia following a physical training pro-
gramme, but this study had small numbers and was not
randomised and therefore gives limited information
about the effect of exercise on muscle performance.
Finally, the effect of an exercise programme on quality of
life in children with haemophilia has yet to be examined.
In other chronic diseases in children, however, exercise
interventions have shown positive effects on quality of
life. Selvadurai et al. [10] reported improvements in qual-
ity of life, as measured by the Quality of Well Being Scale,
in children with cystic fibrosis following an in-hospital
aerobic exercise programme. Recently a disease-specific
quality of life questionnaire (Haemo-QoL) has been vali-
dated in children with haemophilia [11-13]. The effect of
an exercise programme on quality of life can now be
assessed.
The primary aim of this study is to determine the effects of
exercise on aerobic fitness, strength and quality of life in
children with haemophilia. A secondary aim is to examine
the effect of an exercise programme on the frequency and
severity of bleeding episodes.
Study design
This study will be a randomised, assessor-blinded, con-
trolled trial of exercise treatment for children with haemo-
philia. The control group will receive usual medical care
while the intervention group will receive a general exercise
program of 12 weeks duration. Outcomes will be meas-
ured at baseline, on completion of the exercise program at
3 months and at 6 months.
Seventy children with Haemophilia A or B or von Wille-
brand disease who are currently managed through the
haematology clinic at The Children's Hospital at West-
mead and Sydney Children's Hospital will be recruited. To
participate in the study children must be aged between 6
and 18 years, have a diagnosis of mild, moderate or severe
haemophilia (A or B) or von Willebrand disease and the
parent/guardian and child must agree to accept randomi-
sation to either intervention or control group. Subjects
will be excluded if they have any contraindication to aer-
obic or resistance training. Children who are already
involved in regular, organised physical activity lasting
greater than 1 hour for more than 3 sessions per week will
also be excluded.
Methods
Following the screening consultation, baseline measures
will be collected by the researcher. All children will have
baseline anthropometric data recorded (height, weight,
BMI, and body fat using bioelectrical impedance). They
will then undergo fitness testing. This will consist of tests
of grip strength and isokinetic strength testing to assess
quadriceps and hamstrings strength in the non-dominant
leg. In addition a VO2peak test will be performed using aBMC Blood Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2326/6/2
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treadmill protocol. All subjects or their parents/guardians
will complete the Haemo-QoL questionnaire [13] and the
Habitual Activity Estimation Scale (HAES) [14]. The HAES
questionnaire will be used to explain effects of exercise,
should they be apparent, and to determine whether com-
pleting a structured 12 week exercise program increases
levels of habitual activity.
A randomisation schedule will be created with computer-
generated random numbers by a person not otherwise
involved in the recruitment process. The allocation will be
in randomly permuted blocks of 4, 6 and 8. Allocations
will be placed in sequentially numbered, sealed, opaque
envelopes to ensure concealment from the researchers
recruiting subjects, and from the subjects themselves,
prior to randomisation. Potential subjects (or the guardi-
ans of subjects) will be invited to participate in the study
and the methods of the study will be explained to them
verbally and in writing. If they agree to participate base-
line measures will be obtained before the subject is ran-
domised to a group. Subjects will be considered to have
entered the trial at the time the envelope containing their
allocation is opened.
Participants in the control group will receive usual medi-
cal care by their treating haematologist and associated
health practitioners. Their management will include fac-
tor therapy (prophylaxis or "on demand"), as determined
by their treating haematologist. All parents will have been
educated about the disease and been taught how to recog-
nise a bleeding episode. For the purposes of this study
when defining a bleeding episode we have accepted the
definition widely used by other researchers that is, a bleed
is "an episode of bleeding requiring treatment with clot-
ting factor"[15]. Parents will be encouraged to treat bleed-
ing episodes as soon as recognized and advice about
duration of therapy will be given by their treating haema-
tologist.
Participants in the exercise group will receive a super-
vised, general exercise program in addition to their usual
medical care. The exercise program will be conducted for
1 hour, two times per week for 12 weeks. The program will
consist of a supervised "circuit training" programme
including warm-up and warm-down and an age-appropri-
ate mix of resistance exercises and aerobic stations. Aero-
bic training will consist of 30 minutes of continuous
exercise at 60–70% HRmax, depending on baseline fitness
of the participant, as measured by VO2peak test. Resistance
training will follow the traditional "set system" and
involve 20 minutes of upper and lower limb exercises
using isotonic pin-loaded equipment. The training load
will be set at the 8–12 repetition maximum (RM). Sub-
jects will perform 3 sets, each to failure, with the 8–12 RM
load. Throughout the training period the load will be
incremented so that failure occurs at between 8 and 12
repetitions. Ten minutes per session will involve warm-up
and warm-down exercises[16]. The exercise sessions will
be changed frequently to avoid boredom. Patients receiv-
ing prophylactic Factor VIII will administer this prior to
the exercise intervention. A qualified paediatric physical
therapist will conduct and supervise the exercise program.
The therapist will undergo additional training in the aeti-
ology and management of haemophilia and understand
the early management of a bleeding episode.
Participants in the control group will be advised not to
change their physical activity levels during the course of
the trial. In cases where this is unavoidable, a record of the
changes will be kept. Several mechanisms will be used to
ensure that the trial protocol is consistently applied. Pro-
tocol manuals will be developed and the researchers (hae-
matologists, physical therapists, exercise physiologists,
other outcome assessors and the trial manager) will be
trained to ensure that screening, outcome assessment,
allocation and treatment protocols are conducted accord-
ing to the protocol. An independent researcher will ran-
domly audit assessment and treatment sessions to
determine adherence to the protocol. Retraining will be
offered to treatment providers and outcome assessors not
complying with the protocol.
Outcomes
The primary outcomes will be quality of life, strength and
aerobic fitness. The details are as follows:
1. Quality of Life using the Haemo-QoL questionnaire.
This questionnaire has been validated in children with
haemophilia [13]
2.  Quadriceps strength using a Cybex isokinetic
dynamometer [17]
3. VO2peak using the Bruce treadmill protocol [18]
The secondary outcomes are as follows:
1.  Incidence of haemarthroses and intramuscular
bleeds – self-reported for 16 weeks (12 week intervention
period and 4 weeks following)
2. Lean tissue mass, body fat measured using bioelectri-
cal impedance on a body composition analyser
3. Habitual activity using HAES questionnaire [14]
4. Other strength measures
- Isokinetic hamstrings strength using a Cybex isokinetic
dynamometerBMC Blood Disorders 2006, 6:2 http://www.biomedcentral.com/1471-2326/6/2
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- Grip strength using a hand dynamometer [19]
5. Adverse events (other than haemarthroses) associated
with exercise or physical activity. These will be elicited by
open-ended questioning.
All measurements will be taken immediately after the 12
week intervention period, by an assessor blind to group
allocation. (The exception is measurement of bleeding
episodes, which will be monitored as described above.)
Habitual activity and quality of life will be re-measured in
a telephone interview at six months. The number and type
of any adverse effects that occur for the duration of the
study will also be recorded using open-ended question-
ing.
In order to improve compliance and reduce loss to follow-
up, participants in the intervention and control groups
will be telephoned at the beginning of each week. Partici-
pants in the both groups will be asked about bleeding epi-
sodes in the previous week. In addition, participants in
the intervention group will be reminded of their exercise
training schedule. All participants will be asked to keep a
diary to record all bleeding episodes during and for one
month following the intervention period. The final data
on number of bleeds will be a composite of the data
obtained from diaries and from telephone follow-ups.
Sample size and power analysis
A sample size of 70 subjects (35 subjects per group) will
provide an 80% probability of detecting an effect of 0.75
standard deviations on H-QOL scale assuming α of 0.05
and worst-case loss to follow up of 15%.
Data analysis
Data will be analysed by a statistician who is blinded to
group. All analyses will be by intention to treat. That is,
outcome data will be collected regardless of compliance
with the trial protocol, and each patient's data will be ana-
lysed in the group to which the subject was allocated. The
effect of exercise will be estimated with analysis of covari-
ance using a regression approach. To maximise the preci-
sion of estimates, pre-test scores of outcome variables will
be entered into the regression models as covariates. The
uncertainty associated with estimates of the size of effects
of exercise will be quantified with 95% confidence inter-
vals. The integrity of the trial data will be monitored by
regular scrutiny of data sheets for omissions and errors.
Data will be double entered and the source of any incon-
sistencies will be explored and resolved.
Discussion
We have presented the rationale and design for an RCT
examining the effects of exercise on quality of life, fitness
and strength in children with haemophilia. This study has
been designed to include key methodological features rec-
ognised to minimise bias in clinical trials. These features
include: true randomisation using concealed allocation,
blind outcome assessment, blind analysis of results and
intention-to-treat analyses. We have also included practi-
cal measures to minimise the number of dropouts and
maximise compliance with the trial protocol. The results
of this trial will be available in 2008 and will provide
important information likely to affect the lives of children
with haemophilia.
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